Yazar "Avcı, Nilüfer" için listeleme
-
Association and prognostic significance of the functional-1562C/T polymorphism in the promoter region of MMP-9 in Turkish patients with gastric cancer
Avcı, Nilüfer; Türe, Mehmet; Deligönül, Adem; Çubukçu, Erdem; Ölmez, Ömer Fatih; Şahintürk, Serdar; Topak, Ali; Kurt, Ender; Evrensel, Türkan; Şahin, Ahmet Bilgehan; Yakut, Tahsin (Springer, 2015)Matrix metalloproteinases (MMPs) are a group of zinc-dependent peptidases that participate in matrix turnover in solid malignancies. The aim of this study was twofold. First, we sought to investigate under a case-control ... -
The efficacy and safety analysis of the treatments of everolimus and exemestane combination in 101 metastatic breast cancer patients: Real-life experience from Turkey
Bilici, Abdullah Yasin; Menekşe, Serkan; Akın, Şeyma Selin; Değirmenci, Mehmet Fatih Kağan; Ölmez, Ömer Fatih; Avcı, Nilüfer; Sakalar, Teoman; Tural, Deniz; Kaplan, Muhammet Ali; Tanrıverdi, Özgür; Bilgetekin, İrem; Uslu, Rabiye (Amer Assoc Cancer Research, 2019)Background: Endocrine treatment and chemotherapy are a treatment options for patients with hormone receptor (HR) positive and HER2-negative metastatic breast cancer (MBC). However, response to first-line hormone treatment ... -
Medication errors in chemotherapy preparation and administration: A survey conducted among oncology nurses in Turkey
Ulaş, Arife; Sılay, Kamile; Akıncı, Sema; Dede, Didem Şener; Akıncı, Muhammed Bülent; Şendur, Mehmet Ali; Çubukçu, Erdem; Çoşkun, Hasan Şenol; Deǧirmenci, Mustafa; Utkan, Güngör Ör; Özdemir, Nuriye Yıldırım; Işıkdoğan, Abdurrahman; Büyükçeli̇k, Abdullah; İnanç, Mevlüde; Bilici, Ahmet Erkan; Odabaşı, Hatice; Cihan, Şener; Avcı, Nilüfer; Yalçın, Bülent (Asian Pacific Organization for Cancer Prevention, 2015)Background: Medication errors in oncology may cause severe clinical problems due to low therapeutic indices and high toxicity of chemotherapeutic agents. We aimed to investigate unintentional medication errors and underlying ... -
Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy
Avcı, Nilüfer; Deligönül, Adem; Tolunay, Sahsine; Çubukçu, Erdem; Ölmez, Ömer Fatih; Altmışdörtoğlu, Özgür; Tanrıverdi, Özgür; Aksoy, Asude; Kurt, Ender; Evrensel, Türkkan (Zerbinis Publications, 2015)Purpose: The presence of a pronounced tumor lymphocytic infiltrate (TLI) is deemed to reflect the presence of an immunoinflammatory response against the tumor and may thus have prognostic significance. We investigated the ... -
Real-life analysis of efficacy and safety of everolimus plus exemestane in hormone receptor-positive, human epidermal growth factor receptor-2-negative metastatic breast cancer patients: A Turkish Oncology Group (TOG) study
Bilici, Ahmet; Uysal, Mükremin; Menekşe, Serkan; Akın, Semih; Yıldız, Fatih; Turan, Merve; Sezgin Göksu, Sema; Beypınar, İsmail; Sakalar, Teoman; Değirmenci, Mustafa; Erdem, Dilek; Başaran, Gül; Ölmez, Ömer Fatih; Avcı, Nilüfer; Tural, Deniz; Sakin, Abdullah; Türker, Sema; Demir, Atakan; Temiz, Süleyman; Kaplan, Muhammed Ali; Doğan, Mutlu; Tanrıverdi, Özgür; Bilgetekin, İrem; Yeşil Çınkır, Havva; Açıkgöz, Özgür; Paydaş, Semra; Uslu, Rüçhan; Turhal, Serdar (Taylor & Francis Inc, 2022)Purpose: This study evaluated the efficacy and safety of everolimus (EVE) plus exemestane (EXE) in hormone-receptor positive (HR+), human epidermal growth factor receptor-2-negative (HER2−) metastatic breast cancer (MBC) ...